Option chain shows key data for NKGen Biotech's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for NKGen Biotech.

NKGen Biotech (NASDAQ:NKGN) Stock, Option Chain

NKGen Biotech

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Spirit_Airlines-Wikimedia Commons

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AGFY

APVO

BIVI

EFSH

GNPX

ALPS ETF Trusthen & Steers Global Realty Majors ETF

JDZG

LGMK

MTEM

NKGN

PHIO

SAVE

SHLS

TNON

VSEE

VSME

VTAK

XPON

ZPTA

Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket

Wall Street

Equities

Eurozone

Commodities

Intraday Update

DRUG

NFLX

NUZE

ORGS

SOBR

Dow Falls Over 100 Points; Netflix Posts Upbeat Results

AKAN

CETX

ISRG

JTAI

MGPI

NTBL

OLMA

PEGY

STAF

YCBD

Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

NKGen Biotech Inc

Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Apple Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) key suppliers — Hon Hai Precision Industry Co. Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HNHPF#OTC">HNHPF</a>), popularly known as Foxconn, Pegatron Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PGTRF#OTC">PGTRF</a>), and Quanta Computer (OTC:<a class="ticker" href="https://www.benzinga.com/stock/QUCCF#OTC">QUCCF</a>) — plan to quickly increase U.S. investments <a href="https://www.benzinga.com/markets/24/11/41869001/heres-how-trumps-policies-might-shape-the-markets-future">should trade policies shift</a> under Donald Trump&#8217;s second term.
What Happened: Foxconn chairman Young Liu announced on Thursday that the company is ready to expand its U.S. operations. The company is a leading contract electronics manufacturer and has substantial production bases in Texas, Wisconsin, and Ohio.
&#8220;We can very quickly adjust&nbsp;our investment if necessary,&#8221; Liu said at an investor&#8217;s conference, <a href="https://asia.nikkei.com/Spotlight/Supply-Chain/Nvidia-and-Apple-suppliers-ready-to-boost-U.S.-investments-under-Trump">reported</a> Nikkei Asia.
Pegatron, a key supplier to Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Apple, is also prepared to respond swiftly to any policy changes.
&#8220;If necessary, we can quickly convert [our repair facility in Indiana] into production lines to accommodate policy changes [such as tariffs],&#8221; co-CEO Johnson Deng told investors, according to the report.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41927379/elon-musk-says-the-prophecy-has-been-fulfilled-peanut-the-squirrel-themed-meme-coin-spikes-11?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Says The &#8216;Prophecy Has Been Fulfilled&#8217; — Peanut The Squirrel-Themed Meme Coin Spikes 11%</a>
Quanta Computer&#8217;s cloud-computing subsidiary, QCT, is ready to expand its manufacturing capacity in California if needed, said the company&#8217;s president, Mike Yang.
&#8220;We have continued to expand our capacity there in the past two years and have space to further expand anytime if needed. We also have a footprint in Thailand as well.&#8221;
Why It Matters: During his campaign, Trump underscored his &#8220;America First&#8221; agenda and warned of <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41953220/dollar-powers-to-4-month-highs-against-yen-trump-tariff-expectations-spark-carry-trade-frenzy">potential tariffs on various countries</a>, creating uncertainty for the tech supply chain.
Despite these political uncertainties, Foxconn and other leading tech suppliers continue to view artificial intelligence as the key growth driver for the industry through 2025, the report noted.
The stock market and cryptocurrency sector have seen <a href="https://www.benzinga.com/general/social-media/24/11/41912771/trump-presidency-magnificent-7-stock-impact-benzinga-readers-pick-tech-titan-at-most-risk-following-2024-election">significant growth since Trump&#8217;s victory</a>, with major U.S. stock indexes hitting record highs since Trump&#8217;s win against Vice President Kamala Harris.
Earlier this week, Yang Chin-long, the governor of Taiwan's central bank, <a href="https://www.benzinga.com/news/global/24/11/41972365/tsmcs-65b-investment-in-us-will-help-avoid-trade-imbalance-says-taiwan-central-bank-governor-as-trump-returns-to-white-house">voiced optimism about</a> Taiwan Semiconductor Manufacturing Co.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) upcoming $65 billion investment in U.S. factories.
&#8220;Chips and information and telecommunications products are what the U.S. needs most. I don't think the United States would penalize Taiwan,&#8221; he said during a legislative session on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41931993/dogecoin-tumbles-despite-elon-musk-vivek-ramaswamys-doge-appointment-this-is-what-indicators-tell-about-its-next-moves?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Dogecoin Tumbles Despite Elon Musk, Vivek Ramaswamy&#8217;s &#8216;DOGE&#8217; Appointment: This Is What Indicators Tell About Its Next Moves</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

Media

AAPL

HNHPF

MSFT

NVDA

PGTRF

QUCCF

TSLA

Nvidia, Apple Suppliers Brace For Trump's Return: Foxconn, Pegatron, Quanta Prepare For Rapid US Investment Boom

Chinese retail sales grew by 4.8% year-on-year in October picking up from September&#8217;s 3.2% growth, as per the National Bureau of Statistics on Friday. That annual retail sales forecast exceeded the 3.8% growth precited by a Reuters poll.
What Happened: The robust growth in Chinese retail sales in October was fueled by the monetary stimulus measures that the People's Bank of China unveiled in the latter half of September as a last-ditch effort to revive the country's struggling economy.
The share price of the top three Chinese e-commerce players, Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) and JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) were in red in Hong Kong on Friday.
Meanwhile, Alibaba Group Holding&#8216;s American Depository Receipts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) have plunged by 11.90% over the last month, according to <a href="http://pro.benzinga.com">Benzinga Pro data</a>. PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) and JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) ADRs have declined by 13.10% and 18.93%, respectively. The shares have underperformed their index, as the NYSE Composite rose by 0.28%, while the Nasdaq Composite advanced by 4.32% in the same period.
Also read: <a href="https://www.benzinga.com/general/market-summary/24/11/41968003/gold-drops-to-a-two-month-low-as-investors-turn-to-bitcoin-after-trumps-victory-but-this-economist-remains-confident-that-gold-will-surge">Gold Drops To A Two-Month Low As Investors Turn To Bitcoin After Trump&#8217;s Victory, But This Economist Remains Confident That &#8216;Gold Will Surge&#8217;</a>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="252" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15032756/chinese-stocks-1-month-1024x252.png" alt="" class="wp-image-649725" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15032756/chinese-stocks-1-month-1024x252.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15032756/chinese-stocks-1-month-300x74.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15032756/chinese-stocks-1-month-768x189.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15032756/chinese-stocks-1-month-1536x377.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15032756/chinese-stocks-1-month.png 1738w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Why It Matters: The <a href="https://www.benzinga.com/government/regulations/24/11/41843262/chinas-stimulus-plan-not-enough-to-ignite-stocks#:~:text=The%20new%20stimulus%20plan%2C%20confirmed,to%20local%20authorities%2C%20CNBC%20reports.&amp;text=Additionally%2C%20central%20authorities%20will%20issue,over%20the%20next%20five%20years.">Chinese stimulus is aimed at stimulating</a> spending and investment in an economy that's been suffering from weak demand and a cooling property market. The measures also include a stimulus package of around 1 trillion yuan, or more than $140 billion, in liquidity.
Read next: <a href="https://www.benzinga.com/news/earnings/earnings-beats/24/11/41964200/apples-key-supplier-foxconns-gross-profit-hit-7-year-high-in-q3-aims-to-expand-ai-capabilities-by-next-year">Apple&#8217;s Key Supplier Foxconn&#8217;s Gross Profit Hit 7 Year High In Q3, Aims To Expand AI Capabilities By Next Year</a>
Image via Shutterstock

Macro Economic Events

Economics

BABA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Chinese Retail Sales Pickup In October: Here's What's Happening With Alibaba, JD And Pinduoduo Shares

Piper Sandler analyst Arvind Ramnani reiterates Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) with a Overweight and raises the price target from $565 to $575.

Price Target

Reiteration

Analyst Ratings

Piper Sandler Reiterates Overweight on Mastercard, Raises Price Target to $575

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is offering three months of free full self-driving (FSD) subscription and supercharging for customers who take delivery of a new inventory vehicle till the end of the year in North America in a bid to increase annual deliveries.
What Happened: Customers who take delivery of new inventory vehicles between Nov. 14 and Dec. 31 are eligible for the offer. The offer extends to Tesla&#8217;s entire lineup, including its latest offering- the Cybertruck.
Tesla recently added the Cybertruck to its inventory. Until then, potential customers had to customize their vehicles and await delivery instead of picking one from inventory. 
The offer comes amidst Tesla&#8217;s efforts to boost its fourth-quarter delivery numbers. The company is also offering discounts on <a href="https://www.benzinga.com/news/24/10/41443856/tesla-offers-discounts-of-up-to-4k-on-select-model-3-y-vehicles-as-it-looks-to-avert-1st-ever-declin">some inventory vehicles in the U.S. </a>and offers in other offers in geographies <a href="https://www.benzinga.com/tech/24/11/41892379/tesla-offers-a-year-of-supercharging-for-free-in-europe-as-it-chases-record-q4-deliveries-to-outpace-a-slowdown">including Europe.</a> 
Why It Matters:&nbsp;For the full year 2023, Tesla delivered 1,808,581 vehicles around the globe. To mark a growth over last year, the company has to deliver at least 514,926 vehicles in the three months through the end of December. Tesla has never managed to deliver over 500,000 EVs in a quarter to date, making this an <a href="https://www.benzinga.com/tech/24/11/41894615/tesla-q4-deliveries-expected-to-set-new-records-but-not-enough-to-avoid-yearly-sales-decline-says-researcher">ambitious target.</a>
In the third quarter, Tesla reported deliveries of 462,890 vehicles, up 6.4% year-over-year and up 4.3% quarter-over-quarter.
Deliveries fell 8.5% year-on-year in the first quarter and by 4.8% in the second quarter.
Price Action: Tesla shares declined 5.8% on Thursday to $311.18, and were down by 1.9% in premarket trading on Friday. Year-to-date, the Tesla stock has risen by 25.3%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/partner/fintech/24/11/41939694/the-power-of-leverage-global-broker-octa-lays-out-the-ins-and-outs-of-this-trading-tool-for-trade" target="_blank" rel="noreferrer noopener">Ford Cuts Capri, Explorer EV Output Due To ‘Significantly Lower Than Expected Demand' After Pausing F-150 Lightning Production</a></li>
</ul>
Photo courtesy: Tesla

Tesla Offers 3 Months Of Free Supercharging, FSD Subscription For North American Buyers Till Year-End To Boost Deliveries

Reported Earlier, Bloom Energy Announces 1 GW Fuel Cell Deal With AEP, Providing Clean Power For AI Data Centers

Earnings

LNVGY

Reported Earlier, Lenovo Group Q2 EPS $2.78 Up From $1.99 YoY, Revenue $17.850B Up From $14.41B YoY

<h3>Companies Reporting Before The Bell</h3>
• Sigma Lithium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGML#NASDAQ">SGML</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $72.08 million. 
• Trinity Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIB#NASDAQ">TRIB</a>) is projected to report quarterly loss at $0.54 per share on revenue of $16.50 million. 
• Digihost Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGHI#NASDAQ">DGHI</a>) is projected to report quarterly loss at $0.13 per share on revenue of $9.90 million. 
• Aegon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEG#NYSE">AEG</a>) is projected to report earnings for its third quarter. 
• Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) is expected to report earnings for its third quarter. 
• WiSA Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>) is likely to report quarterly loss at $0.68 per share on revenue of $1.00 million. 
• AIM ImmunoTech (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AIM#AMEX">AIM</a>) is likely to report quarterly loss at $0.10 per share on revenue of $20 thousand. 
• Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) is likely to report quarterly earnings at $0.10 per share on revenue of $87.84 million. 
• RLX Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLX#NYSE">RLX</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $105.08 million. 
• Alibaba Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) is projected to report quarterly earnings at $2.10 per share on revenue of $33.95 billion. 
• Spectrum Brands Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPB#NYSE">SPB</a>) is estimated to report quarterly earnings at $1.02 per share on revenue of $746.54 million. 
<h3>Companies Reporting After The Bell</h3>
• Neurogene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGNE#NASDAQ">NGNE</a>) is likely to report earnings for its third quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BPTH

DGHI

NEXN

NGNE

SGML

TRIB

WISA

Earnings Scheduled For November 15, 2024

<ul>
<li>Muñoz to lead Hyundai Motor Company's global business</li>
<li>Continues to serve on the Hyundai Motor Company Board of Directors</li>
</ul>
Hyundai Motor Company (HMC) today announced the appointment of José Muñoz as the company's President and CEO, effective Jan. 1, 2025. Muñoz will lead Hyundai Motor Company's global business, succeeding current President and CEO Jaehoon Chang, who has been promoted to the Vice Chair of Hyundai Motor Group – Automotive Division.

Management

HYMLF

HYMTF

Reported Earlier, Hyundai Motor Company Names José Muñoz As President And Chief Executive Officer, Effective January 1, 2025

Econ #s

France Harmonised Index of Consumer Prices (MoM) For October 0.3% Vs. 0.3% Est.; -1.3% Prior

France Consumer Price Index (MoM) For October 0.3% Vs. 0.2% Est.; -1.3% Prior

OneStream, Inc announced today the pricing of the previously announced underwritten public offering of 15,000,000 shares of its Class&nbsp;A common stock, at a public offering price of $31.00 per share, of which 9,006,948 shares will be sold by selling stockholders and 5,993,052 shares will be sold by OneStream as part of a non-dilutive "synthetic secondary" transaction (the "Synthetic Secondary").

Reported Earlier, OneStream Prices Secondary Offering Of 15M Class A Common Stock At $31/Share

Associated expects to use the net proceeds from this offering for general corporate purposes to support continued organic growth and capital generation, which may include investments in Associated Bank, N.A. and potential balance sheet optimization strategies.

Reported Earlier, Associated Banc-Corp Prices $300M Public Offering Of 12M Common Stock Offering At $25/Share

In a unique perspective, a cryptocurrency analyst equated Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) to gunpowder, arguing that sooner or later sovereign nations would be compelled to adopt the leading cryptocurrency.
What Happened: Matt Huang, CEO of cryptocurrency-focused investment firm Paradigm, penned a blog post Thursday, highlighting Bitcoin&#8217;s growing prominence. 
Huang argued that like gunpowder became indispensable after its discovery, the same would eventually pan out for emerging technologies like artificial intelligence, drones, and Bitcoin.
&#8220;Sovereigns can no longer afford to dismiss BTC. From a game theoretic perspective, BTC is like gunpowder, not the iPhone. Christopher,&#8221; the analyst remarked.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Bitcoin for the Sovereign <a href="https://t.co/HD1UpcD6J7">pic.twitter.com/HD1UpcD6J7</a>
&mdash; Matt Huang (@matthuang) <a href="https://twitter.com/matthuang/status/1857127295145902586?ref_src=twsrc%5Etfw">November 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Huang highlighted how calls for the establishment of a Bitcoin strategic reserve have intensified since Donald Trump&#8217;s presidential victory, suggesting the opening of the Overton window for Bitcoin acceptance in America.
&#8220;Sovereigns that build BTC reserves early will benefit from significantly better entry prices. The race to build BTC reserves is on.&#8221;
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41912787/buckle-up-for-the-bull-markets-most-fun-phase-says-industry-expert-bitcoin-ethereum-dogecoin-about-to-enter-the-euphoria-stage?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;Buckle Up&#8217; For The Bull Market&#8217;s &#8216;Most Fun Phase,&#8217; Says Industry Expert: Bitcoin, Ethereum, Dogecoin Abo</a>
Why It Matters: The Republican side vigorously promoted the idea of a Bitcoin reserve leading up to the elections, with none other than President-elect Trump <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40001426/trump-aims-to-make-us-crypto-capital-of-the-planet-well-get-it-done">vowing to establish one</a> if voted to power.
A few days later, Senator Cynthia Lummis (R-Wyo.) <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40087880/cynthia-lummis-unveils-strategic-bitcoin-reserve-legislation-this-is-our-louisiana-purchas">proposed </a>a bill, called the BITCOIN Act, aimed at creating a strategic Bitcoin stockpile to support America's balance sheet.
The senator reiterated her pledge following the Republican Party&#8217;s electoral triumph last week, as Polymarket odds showed a <a href="https://polymarket.com/event/will-trump-create-a-national-bitcoin-reserve-in-his-first-100-days?tid=1731494882651">35%</a> probability of this happening.
Moreover, emboldened by broader support, Pennsylvania introduced the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41986427/pennsylvania-introduces-bitcoin-strategic-reserve-act-to-invest-up-to-700-million-in-btc">Bitcoin Strategic Reserve Act</a>, hoping to build its own state-held Bitcoin reserve.
Price Action: At the time of writing, Bitcoin was trading at $87,824.55, down 2.35% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/41998869/analyst-says-bitcoin-lives-rent-free-in-peoples-minds-after-peter-schiffs-cheeky-social-security-trust-remark">Peter Schiff&#8217;s Cheeky Bitcoin Turnaround Post Earns Reaction From Popular Analyst: &#8216;You Buy It And Become Rich Or You Keep Hating And Turn Crazy&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Is Like Gunpowder And That Is Why Sovereign States Can't Refuse Its Adoption, Says Crypto Analyst

Buybacks

SNDL

Reported Earlier, SNDL Extends Share Repurchase Program With C$100M Authorization, Aiming To Repurchase Up To 13.2M Shares

Equus Total Return, Inc. (NYSE:<a href="https://www.benzinga.com/stock/EQS#NYSE">EQS</a>) ("Equus" or the "Company") reports net assets as of September 30, 2024, of $40.2 million. Net asset value per share decreased to $2.96 as of September 30, 2024, from $3.66 as of June 30, 2024. Comparative data is summarized below (in thousands, except per share amounts):&nbsp;&nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>As of the Quarter Ended</td>
<td>9/30/2024</td>
<td>6/30/2024</td>
<td>3/31/2024</td>
<td>12/31/2023</td>
<td>9/30/2023 &nbsp;</td>
</tr>
<tr>
<td>Net assets</td>
<td>$40,165</td>
<td>$49,792</td>
<td>$45,892</td>
<td>$48,287</td>
<td>$47,128</td>
</tr>
<tr>
<td>Shares outstanding</td>
<td>13,586</td>
<td>13,586</td>
<td>13,586</td>
<td>13,586</td>
<td>13,518</td>
</tr>
<tr>
<td>Net assets per share</td>
<td>$2.96</td>
<td>$3.66</td>
<td>$3.38</td>
<td>$3.55</td>
<td>$3.49</td>
</tr>
</tbody>
</table>
</figure>

Reported Earlier, Equus Total Return Reports Net Assets As Of September 30, 2024, Of $40.2M; Net Asset Value Per Share $2.96

ZLAB

Reported Earlier, Zai Lab Prices 7.8M American Depositary Shares At $25.50/ADS In $200M Public Offering

Maui Land &amp; Pineapple Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLP#NYSE">MLP</a>) reported quarterly losses of $(0.07) per share. This is a 16.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $3.02 million in sales this quarter. This is a 43.98 percent increase over sales of $2.10 million the same period last year.

Maui Land & Pineapple Co Q3 EPS $(0.07) Down From $(0.06) YoY, Sales $3.02M Up From $2.10M YoY

GreenPower Motor Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GP#NASDAQ">GP</a>) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. The company reported quarterly sales of $5.347 million which missed the analyst consensus estimate of $7.967 million by 32.88 percent. This is a 36.35 percent decrease over sales of $8.400 million the same period last year.

Earnings Misses

GreenPower Motor Co Q2 2025 GAAP EPS $(0.18) Misses $(0.16) Estimate, Sales $5.347M Miss $7.967M Estimate

Beam Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEEM#NASDAQ">BEEM</a>) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.12) by 175 percent. The company reported quarterly sales of $11.482 million which missed the analyst consensus estimate of $18.863 million by 39.13 percent. This is a 30.35 percent decrease over sales of $16.486 million the same period last year.

Earnings Beats

BEEM

Beam Global Q3 2024 GAAP EPS $0.09 Beats $(0.12) Estimate, Sales $11.482M Miss $18.863M Estimate

Lantmännen will invest more than 100 million euros in a state-of–the-art <a href="https://www.globenewswire.com/Tracker?data=D-7Y-KVbP6QZknfadXEZ-FyiOL801tmcb6MoPLIt1GBtRzzMxYqB5y0WMAfkDOuP8wF9RdBMPWvDS7IIKC_OkWudCUCt9vi-8ARGYU9fdadf5aFadydlfMoC2c0oEek0wq9shl6f0tFxH4iEsBbG2plhHfhgHB7WME97-NbSZIM6dfFRmaj3AkU_gZXrXeRD6wSfFlbL5NZEKQdFWd05Ix8BUt1dMN_MHpAiD0GLnSSve8knOhEkT3alPDLqD0Z4qqemEbKkxRZ3MJ3oKFuKXBYY26VDZ92n-tTgubAPhQo=">factory in Sweden</a>, while partnering with Ingredion to develop a differentiated portfolio of plant-based protein isolates based on yellow peas. Construction of the production plant will be completed in 2027.

INGR

Reported Earlier, Ingredion And Lantmännen Forge Strategic Alliance To Boost European Plant-Based Protein Market, Invest Over €100M In New Pea Protein Facility

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
NKGen Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/nkgn-stock-quote/">NKGN</a>) stock is rocketing higher on Thursday as the clinical-stage biotechnology company prepares to <a href="https://finance.yahoo.com/news/nkgen-biotech-present-positive-snk01-120500650.html">present new biomarker data on SNK01</a>.



This is the company&rsquo;s treatment candidate for Alzheimer&rsquo;s disease. It&rsquo;s going to provide this data to those attending the Alzheimer&rsquo;s Association International Conference. This is set to take place from July 28 through Aug. 1.



The focus of the presentation will be on SNK01&rsquo;s ability to reduce &alpha;-synuclein in Alzheimer&rsquo;s patients. That&rsquo;s important as &alpha;-synuclein has been tied to worse cognitive function for Alzheimer&rsquo;s patients.



NKGen Biotech will hold its press conference on July 30. It will start at 7:30 a.m. Eastern Time. The event will end at 4:15 p.m. Eastern Time that same day. Hosting the event is company chairman and CEO Paul Song.



<h2>How This Affects NKGN Stock</h2>



NKGN stock is already up 17.7% as of Thursday morning alongside excitement for the upcoming presentation. This brings with it heavy trading with more than 33 million shares changing hands. That&rsquo;s already well above its daily average trading volume of about 1.5 million shares.



It&rsquo;s also possible that NKGN stock will see another rally alongside its presentation. That means investors will want to check back in on it when July 30 rolls around.



Here are more of the most recent stock market stories that traders need to know about on Thursday!



We are offering coverage of all of the latest stock market news for today! That includes what&rsquo;s happening with shares of Agenus&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/agen-stock-quote/">AGEN</a>) stock, Lilium&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/lilm-stock-quote/">LILM</a>) stock and Wayfair&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/w-stock-quote/">W</a>) today. All of this news is ready at the links below!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-agenus-agen-stock-down-55-today/">Why Is Agenus (AGEN) Stock Down 55% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/lilm-stock-pops-as-lilium-bags-evtol-jet-order/">LILM Stock Pops as Lilium Bags eVTOL Jet Order</a></li>



<li><a href="https://investorplace.com/2024/07/dear-wayfair-stock-fans-mark-your-calendars-for-july-26/">Dear Wayfair Stock Fans, Mark Your Calendars for July 26</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-nkgen-biotech-nkgn-stock-up-18-today-july-18th/">Why Is NKGen Biotech (NKGN) Stock Up 18% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is NKGen Biotech (NKGN) Stock Up 18% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Warner Bros. (NASDAQ:<a href="https://investorplace.com/stock-quotes/wbd-stock-quote/">WBD</a>) stock is in the news Thursday as investors react to reports that the entertainment company is <a href="https://finance.yahoo.com/video/warner-bros-discovery-considering-break-140403992.html">considering a spinoff</a> of its streaming division.



According to these reports, Warner Bros. is weighing options that would have it breaking up its business. That includes splitting off its streaming and studio businesses from its television division.



Reports of this plan come as Warner Bros. continues to deal with growing debt. The company is still sitting with $39 billion of debt and that&rsquo;s one of the factors that&rsquo;s weighing down its shares recently.



<h2>WBD Stock Reaction Today</h2>



Investors in Warner Bros. appear excited about the prospect of the company splitting off its streaming division. These reports sent shares of WBD 6.6% higher on Thursday morning.



Alongside that rally comes increased trading of WBD stock. This has nearly 32 million shares of the stock changing hands as of this writing. To put that in perspective, the company&rsquo;s daily average trading volume is about 29.1 million shares.



While WBD stock is up on Thursday, it&rsquo;s been a rough year for the company&rsquo;s shares. Year-to-date the stock is still down 24%. It&rsquo;s also 30.6% lower over the last 12 months.



Investors who are seeking out even more of the most recent stock market stories are going to want to keep reading!



We are offering up insight into all of the biggest stock market news that traders need to know about on Thursday! Among that is what has shares of NKGen Biotech&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nkgn-stock-quote/">NKGN</a>), Trump Media &amp; Technology Group&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/djt-stock-quote/">DJT</a>) and Agenus&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/agen-stock-quote/">AGEN</a>) stock moving today. You can find out more on these matters down below!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-nkgen-biotech-nkgn-stock-up-18-today-july-18th/">Why Is NKGen Biotech (NKGN) Stock Up 18% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/trump-media-stock-alert-sec-sues-former-digital-world-ceo-patrick-orlando/">Trump Media Stock Alert: SEC Sues Former Digital World CEO Patrick Orlando</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-agenus-agen-stock-down-55-today/">Why Is Agenus (AGEN) Stock Down 55% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/wbd-stock-pops-as-warner-bros-considers-streaming-spinoff/">WBD Stock Pops as Warner Bros. Considers Streaming Spinoff</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

WBD Stock Pops as Warner Bros. Considers Streaming Spinoff

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Intuitive Surgical (NASDAQ:<a href="https://investorplace.com/stock-quotes/isrg-stock-quote/">ISRG</a>) stock is on the move Thursday after the company&rsquo;s shares were given a <a href="https://www.streetinsider.com/Analyst+PT+Change/Intuitive+Surgical+%28ISRG%29+PT+Raised+to+%24490+at+Barclays/23476587.html">price target increase</a> by Barclays analysts.



Barclays analyst Matt Miksic increased the firm&rsquo;s price target for ISRG stock from $430 per share to $490 per share. That&rsquo;s a potential upside of 17.5% over its prior closing price. It&rsquo;s also above the <a href="https://www.marketbeat.com/stocks/NASDAQ/ISRG/forecast/">analysts&rsquo; consensus price prediction</a> of $426.53 per share.



The Barclays analyst reiterated the firm&rsquo;s &ldquo;overweight&rdquo; rating for ISRG stock alongside that price target increase. For comparison, the analysts&rsquo; consensus rating for Intuitive Surgical shares is moderate buy based on 19 opinions.



<h2>More Analyst Coverage of ISRG Stock</h2>



&nbsp;J.P. Morgan analysts also recently weighed in on Intuitive Surgical. Here&rsquo;s <a href="https://www.medtechdive.com/news/jj-abbott-intuitive-medtech-earnings-q2/721427/">what they said</a> in a statement collected by MedTechDive. 




&ldquo;We think, if anything, the environment has improved modestly in China barring competitive headwinds, and while bariatric surgery should continue to remain pressured, given the low to mid-single digit % of procedures, we aren&rsquo;t overly concerned.&rdquo;




ISRG stock is down 2.5% as of Thursday afternoon. This comes with some 1.7 million shares traded, as compared to its daily average of about 1.3 million shares.



Investors will want to stick around for more of the most recent stock market stories today!



We have all of the hottest stock market news investors will want to read about on Thursday! A few examples include what&rsquo;s happening with shares of Oklo&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/oklo-stock-quote/">OKLO</a>), Warner Bros.&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wbd-stock-quote/">WBD</a>) and NKGen Biotech&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nkgn-stock-quote/">NKGN</a>) stock today. All of this info is ready at the links below!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/07/cathie-wood-is-betting-big-on-nuclear-energy-via-oklo-stock-what-to-watch/">Cathie Wood Is Betting Big on Nuclear Energy Via Oklo Stock. What to Watch.</a></li>



<li><a href="https://investorplace.com/2024/07/wbd-stock-pops-as-warner-bros-considers-streaming-spinoff/">WBD Stock Pops as Warner Bros. Considers Streaming Spinoff</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-nkgen-biotech-nkgn-stock-up-18-today-july-18th/">Why Is NKGen Biotech (NKGN) Stock Up 18% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/barclays-just-raised-its-price-target-on-intuitive-surgical-isrg-stock/">Barclays Just Raised Its Price Target on Intuitive Surgical (ISRG) Stock</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Barclays Just Raised Its Price Target on Intuitive Surgical (ISRG) Stock

NKGen Biotech (NKGN) has issued an announcement. Pierre Gagnon has stepped down from his role as Chief Operating Officer of NKGen Biotech, Inc., ef...

NKGen Biotech COO Pierre Gagnon Steps Down, Remains Advisor

NKGen Biotech receives non-compliance notification from Nasdaq

An announcement from NKGen Biotech (NKGN) is now available. NKGen Biotech, Inc. is facing a delay in submitting its quarterly financial report due ...

NKGen Biotech Faces Nasdaq Compliance Challenges

NKGen Biotech ( ($NKGN) ) has shared an update. NKGen Biotech, Inc. is set to join the H.C. Wainwright 26th Annual Global Investment Conference on ...

NKGen Biotech to Showcase at Global Investment Conference

NKGen Biotech ( ($NKGN) ) has provided an update. NKGen Biotech, Inc. has amended its forward purchase agreement to increase both the prepayment sh...

NKGen Biotech Expands Agreement Terms and Restructures COO Role

NKGen Biotech ( ($NKGN) ) just unveiled an update. NKGen Biotech, Inc. is experiencing a significant change in its leadership structure as director...

NKGen Biotech Announces Leadership Shuffle on Anniversary

NKGen Biotech ( ($NKGN) ) just unveiled an update. NKGen Biotech Inc. has announced the appointment of Michael Klowden and Kathleen Scott as new di...

NKGen Biotech Welcomes New Directors and Assigns Committees

AGEN

LILM

OKLO

Health Care

Press Releases

NKGen Biotech to Present New Positive SNK01 Clinical Trial Biomarker Data at the 2024 Alzheimer's Association International Conference

NKGen Biotech Presents New Positive SNK01 Biomarker Data at the 2024 Alzheimer's Association International Conference

NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report

NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NKGen Biotech's Positive Phase 1 Clinical Data in Moderate Alzheimer's Disease Advances Troculeucel into Phase 2 with First Patient Dosed in Phase 1/2a Trial

NKGen Biotech Announces Poster Presentations at the 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference

NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)

NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference

Comments

NKGen Biotech

NKGen Biotech (NKGN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga